Jennifer Ruff
Investor Relations Contact at DIANTHUS THERAPEUTICS, INC.
Jennifer Ruff active positions
| Companies | Position | Start | End |
|---|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Investor Relations Contact | 29/11/2023 | - |
Career history of Jennifer Ruff
Former positions of Jennifer Ruff
| Companies | Position | Start | End |
|---|---|---|---|
| PYXIS ONCOLOGY, INC. | Investor Relations Contact | 01/01/2023 | 01/11/2023 |
| TESARO INC | Investor Relations Contact | 01/03/2013 | 01/10/2018 |
| Public Communications Contact | 01/03/2013 | 01/10/2018 | |
| PFIZER, INC. | Investor Relations Contact | 01/06/2007 | 01/03/2013 |
MGI PHARMA Biologics, Inc.
 MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA Biologics, Inc. develops and markets pharmaceutical and medical therapies. The company's products amolimogene and ZYC300 represent a breakthrough in the activition of cytotoxic cells. The company was founded in 1979 and is located in Lexington, MA | Public Communications Contact | 01/04/2003 | 01/05/2007 |
Training of Jennifer Ruff
| Northwestern University | Graduate Degree |
| University of Iowa | Undergraduate Degree |
Statistics
International
| United States | 8 |
Operational
| Investor Relations Contact | 4 |
| Public Communications Contact | 2 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| PYXIS ONCOLOGY, INC. | Health Technology |
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private companies | 2 |
|---|---|
MGI PHARMA Biologics, Inc.
MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA Biologics, Inc. develops and markets pharmaceutical and medical therapies. The company's products amolimogene and ZYC300 represent a breakthrough in the activition of cytotoxic cells. The company was founded in 1979 and is located in Lexington, MA | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Jennifer Ruff
- Experience
